NOT-DC-25-004: Notice of NIDCD Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice of NIDCD Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice Number:

NOT-DC-25-004

Key Dates

Release Date:

October 9, 2024

Related Announcements

October 2, 2024 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed). See NOFO PA-25-080.

Issued by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

The purpose of this Notice is to inform potential applicants October 8, 2024 the National Institute on Deafness and Other Communication Disorders (NIDCD) will participate in PA-25-080 “NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)” issued by the National Institutes of Health.

The following text has been added to reflect NIDCD's participation:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Deafness and Other Communication Disorders (NIDCD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.173

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Judith Cooper, Ph.D.
National Institute on Deafness and Other Communication Disorders (NIDCD)
Phone: 301-496-5061
Email: cooperj@mail.nih.gov